Harley-Davidson Inc vs Inovio Pharmaceuticals Inc — how do they compare? Harley-Davidson Inc trades at $26.91 (market cap $2.78B), while Inovio Pharmaceuticals Inc trades at $0.8 (market cap $78.55M). The key difference: Harley-Davidson Inc is far larger — about 35.4× Inovio Pharmaceuticals Inc's market cap, and Harley-Davidson Inc pays a 2.75% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| HOG | INO | |
|---|---|---|
Market Cap | $2.78B | $78.55M |
Sector | Consumer Cyclical | Health |
52-Week High | $31.03 | $2.87 |
52-Week Low | $17.19 | $0.66 |
Enterprise Value | $3.19B | $49.56M |
Dividend Yield | 2.75% | — |
Trailing returns across standard periods
Harley-Davidson is a global leading manufacturer of heavyweight motorcycles, merchandise, parts, and accessories. It sells custom, cruiser, and touring motorcycles and offers a complete line of Harley-Davidson motorcycle parts, accessories, riding gear, and apparel, as well as merchandise. Harley-Davidson Financial Services provides wholesale financing to dealers and retail financing and insurance brokerage services to customers. Harley has historically captured about half of all heavyweight domestic retail motorcycle registrations, a metric it had ceded in 2020 as it repositioned the business, but a level it is working back toward. In recent years the firm has expanded into the adventure touring market with its Pan America model and into electric with the LiveWire brand.
Read more on HOG →Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →